NLRP3 and Parkinson disease: In conclusion, although several studies have shown that α-synuclein can elicit activation of inflammasome in monocyte and microglial cell lines and in PD animal models, the possible role of NLRP3 in patients with a diagnosis of PD still needs to be clarified.